Clinical Trial Update: Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating anti-CD19 CAR-NK cells in patients with refractory/relapsed systemic lupus erythematosus. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Anti-CD19 CAR-NK cells (Chimeric Antigen Receptor NK cell therapy targeting CD19)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING